Role of proton therapy in reirradiation and in the treatment of sarcomas.
Proton Therapy
Protonthérapie
Reirradiation
Réirradiation
Sarcoma
Sarcome
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
31
05
2021
revised:
11
06
2021
accepted:
16
06
2021
pubmed:
22
7
2021
medline:
1
10
2021
entrez:
21
7
2021
Statut:
ppublish
Résumé
Reirradiation and irradiation of sarcoma is often difficult due to the frequent need for a high dose of radiation in order to increase tumor control. This can result in a greater risk of toxicity which can be mitigated with the use of proton therapy. The present review aims to summarize the role of proton therapy in these 2 clinical contexts.
Identifiants
pubmed: 34284969
pii: S1278-3218(21)00123-2
doi: 10.1016/j.canrad.2021.06.024
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
550-553Informations de copyright
Copyright © 2021 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.